Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 9,640 shares (to pay taxes)
  9. 4 Shares withheld for taxes CBO & COO gave up 3,112 shares (to pay taxes)
  10. 4 Shares withheld for taxes General Counsel and Secretary gave up 2,360 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Chief Executive Officer acquired 17,750 shares (option exercise)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 37,818 shares (to pay taxes)
  17. 4 Shares withheld for taxes CBO & COO gave up 11,185 shares (to pay taxes)
  18. 4 Shares withheld for taxes Executive VP, Head of R&D gave up 12,607 shares (to pay taxes)
  19. 4 Shares withheld for taxes General Counsel and Secretary gave up 6,303 shares (to pay taxes)
  20. 4 Exercise or conversion General Counsel and Secretary acquired 7,342 shares (option exercise)

Page 10 of 26 · 502 filings